/
/
/

Transgene Biotek Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)2.64
Volume (₹)9,946.00
High (₹)2.65
Upper Circuit3.16
Low (₹)2.48
Lower Circuit2.12
Prev Close2.64
52W High (₹)4.39
Price2.52
52W Low (₹)1.83

Share Market Cap & Key Ratios Overview

M.Cap (₹)20.00 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity1.45
Price to Book2.53
Book Value1.32
EPS (TTM)-0.21
Face Value10.00
ROE (%)-6.52

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SAGILITY-ANSE
SYNGENE-ANSE
INDGN-ANSE
IGIL-ANSE
NESCO-ANSE
JUSTDIAL-ANSE
LATENTVIEW-ANSE
CMSINFO-ANSE
MEDIASSIST-ANSE
AWFIS-ANSE
TRABI-XNSE
LTP
1W Low
1W High
Market cap (₹)
45.36+1.41 (3.21%)
42.77
46.10
21,347Cr
383+35.7 (10.28%)
353.90
397.70
15,759Cr
588.4+8.2 (1.41%)
567.80
599.25
14,375Cr
321.3+12.2 (3.95%)
308
323.40
13,650Cr
1046+8.4 (0.81%)
1029.30
1057
7,413Cr
682.25+34.15 (5.27%)
643.75
687.10
5,814Cr
238+6 (2.59%)
231.35
247.45
5,044Cr
217.9+3.4 (1.59%)
213.50
222
3,485Cr
306.2+5.3 (1.76%)
297.80
314.25
2,268Cr
241.75-5.4 (-2.18%)
241
254.05
1,804Cr
2.52+0.05 (2.02%)
2.45
2.94
20Cr

Key Highlights of Transgene Biotek Ltd Balance Sheet

Transgene Biotek Ltd balance sheet discloses shareholders' funds of ₹75.77Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹75.77Cr, and the reserves and surplus of the company is -₹83.32Cr.

The company has its non-current liabilities with total liabilities of ₹34.2Cr as of 2025-03-31.

The current liabilities are ₹12.62Cr as of 2025-03-31. At the same time, current assets are ₹1.26Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹9.5Lakh and tangible assets of ₹7.96Cr, provided in the Transgene Biotek Ltd financial statements.